MicroRNA Regulation by RNA-binding Proteins and Its Implications for Cancer

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2011 Aug 9

PMID 21822212

Citations 357

Authors

Marieke Van Kouwenhove

Martijn Kedde

Reuven Agami

Affiliations

Soon will be listed here.

Abstract

Non-protein-coding transcripts have been conserved throughout evolution, indicating that crucial functions exist for these RNAs. For example, microRNAs (miRNAs) have been found to modulate most cellular processes. The protein classes of RNA-binding proteins include essential regulators of miRNA biogenesis, turnover and activity. RNA-RNA and protein-RNA interactions are essential for post-transcriptional regulation in normal development and may be deregulated in disease. In reviewing emerging concepts of the interplay between miRNAs and RNA-binding proteins, we highlight the implications of these complex layers of regulation in cancer initiation and progression.

Citing Articles

Structural, biological, and biomedical implications of mRNA interactions with the master regulator HuR.

Clark M, Farinha A, Morrison A, Lisi G NAR Mol Med. 2025; 2(1):ugaf002.

PMID: 39980665 PMC: 11838611. DOI: 10.1093/narmme/ugaf002.

ESRP2-microRNA-122 axis promotes the postnatal onset of liver polyploidization and maturation.

Bangru S, Chen J, Baker N, Das D, Chembazhi U, Derham J Genes Dev. 2025; 39(5-6):325-347.

PMID: 39794125 PMC: 11874994. DOI: 10.1101/gad.352129.124.

HNRNPC as a pan-cancer biomarker and therapeutic target involved in tumor progression and immune regulation.

Zhang Y, Zhang Z, Dong J, Liu C Oncol Res. 2024; 33(1):83-102.

PMID: 39735682 PMC: 11671622. DOI: 10.32604/or.2024.055866.

A Thorough Navigation of miRNA's Blueprint in Crafting Cardiovascular Fate.

Nazir A, Uwishema O, Shariff S, Franco W, El Masri N, Ayele N Health Sci Rep. 2024; 7(11):e70136.

PMID: 39502130 PMC: 11535861. DOI: 10.1002/hsr2.70136.

MicroRNA-130a-3p regulates osimertinib resistance by targeting runt-related transcription factor 3 in lung adenocarcinoma.

Shintani T, Shun Y, Toyozumi Y, Ikemura K, Shiroyama T, Nagatomo I Sci Rep. 2024; 14(1):24429.

PMID: 39424918 PMC: 11489462. DOI: 10.1038/s41598-024-76196-1.

References

Lunde B, Moore C, Varani G . RNA-binding proteins: modular design for efficient function. Nat Rev Mol Cell Biol. 2007; 8(6):479-90. PMC: 5507177. DOI: 10.1038/nrm2178. View

MacRae I, Zhou K, Doudna J . Structural determinants of RNA recognition and cleavage by Dicer. Nat Struct Mol Biol. 2007; 14(10):934-40. DOI: 10.1038/nsmb1293. View

Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M . miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci U S A. 2008; 105(51):20297-302. PMC: 2629338. DOI: 10.1073/pnas.0809376106. View

Kedde M, Van Kouwenhove M, Zwart W, Vrielink J, Elkon R, Agami R . A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol. 2010; 12(10):1014-20. DOI: 10.1038/ncb2105. View

Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T, Hammond S . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006; 20(16):2202-7. PMC: 1553203. DOI: 10.1101/gad.1444406. View

Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis M, Nervi C . A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell. 2005; 123(5):819-31. DOI: 10.1016/j.cell.2005.09.023. View

Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale J, Gorospe M . Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 2004; 23(15):3092-102. PMC: 514922. DOI: 10.1038/sj.emboj.7600305. View

Olson P, Lu J, Zhang H, Shai A, Chun M, Wang Y . MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009; 23(18):2152-65. PMC: 2751988. DOI: 10.1101/gad.1820109. View

Jafarifar F, Yao P, Eswarappa S, Fox P . Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J. 2011; 30(7):1324-34. PMC: 3094116. DOI: 10.1038/emboj.2011.38. View

10.

Brennan S, Kuwano Y, Alkharouf N, Blackshear P, Gorospe M, Wilson G . The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 2009; 69(12):5168-76. PMC: 2724875. DOI: 10.1158/0008-5472.CAN-08-4238. View

11.

Kedde M, Strasser M, Boldajipour B, Vrielink J, Slanchev K, le Sage C . RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell. 2007; 131(7):1273-86. DOI: 10.1016/j.cell.2007.11.034. View

12.

le Sage C, Nagel R, Egan D, Schrier M, Mesman E, Mangiola A . Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007; 26(15):3699-708. PMC: 1949005. DOI: 10.1038/sj.emboj.7601790. View

13.

Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L . miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002; 16(6):720-8. PMC: 155365. DOI: 10.1101/gad.974702. View

14.

Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T . Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004; 15(2):185-97. DOI: 10.1016/j.molcel.2004.07.007. View

15.

Voorhoeve P, le Sage C, Schrier M, Gillis A, Stoop H, Nagel R . A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006; 124(6):1169-81. DOI: 10.1016/j.cell.2006.02.037. View

16.

Hutvagner G . Small RNA asymmetry in RNAi: function in RISC assembly and gene regulation. FEBS Lett. 2005; 579(26):5850-7. DOI: 10.1016/j.febslet.2005.08.071. View

17.

Djuranovic S, Nahvi A, Green R . A parsimonious model for gene regulation by miRNAs. Science. 2011; 331(6017):550-3. PMC: 3955125. DOI: 10.1126/science.1191138. View

18.

Bernstein E, Caudy A, Hammond S, Hannon G . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001; 409(6818):363-6. DOI: 10.1038/35053110. View

19.

Garnon J, Lachance C, Di Marco S, Hel Z, Marion D, Ruiz M . Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level. J Biol Chem. 2004; 280(7):5750-63. DOI: 10.1074/jbc.M401988200. View

20.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View